As at Jun 12, 2026, the MEDP stock has a price-to-earnings ratio of 28.81. This is based on the current EPS of $16.22 and the stock price of $467.34 per share. A decrease of 7% has been recorded in the PE ratio compared to the average of 30.8 of the last four quarters.
The mean historical PE ratio of Medpace Holdings over the last ten years is 39.52. The current 28.81 P/E ratio is 27% lower than the historical average. In the past ten years, MEDP's PE ratio peaked in the Sep 2016 quarter at 248.83, with a price of $29.86 and an EPS of $0.12. The Mar 2025 quarter marked the lowest point at 22.55, with a price of $304.69 and an EPS of $13.51.
Maximum annual increase: 41.16% in 2025
Maximum annual decrease: -61.8% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 35.91 | 41.16% | $561.65 | $15.64 |
| 2024 | 25.44 | -23.65% | $332.23 | $13.06 |
| 2023 | 33.32 | 18.75% | $306.53 | $9.2 |
| 2022 | 28.06 | -34.76% | $212.41 | $7.57 |
| 2021 | 43.01 | 25.76% | $217.64 | $5.06 |
| 2020 | 34.2 | 13.51% | $139.2 | $4.07 |
| 2019 | 30.13 | 16.69% | $84.06 | $2.79 |
| 2018 | 25.82 | -28.79% | $52.93 | $2.05 |
| 2017 | 36.26 | -61.8% | $36.26 | $1 |
| 2016 | 94.92 | N/A | $36.07 | $0.38 |
| 2015 | N/A | N/A | N/A | -$0.28 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 29.6 | -17.57% | $480.19 | $16.22 |
| Dec 2025 | 35.91 | 2.4% | $561.65 | $15.64 |
| Sep 2025 | 35.07 | 54.43% | $514.16 | $14.66 |
| Jun 2025 | 22.71 | 0.71% | $313.86 | $13.82 |
| Mar 2025 | 22.55 | -11.36% | $304.69 | $13.51 |
| Dec 2024 | 25.44 | -9.85% | $332.23 | $13.06 |
| Sep 2024 | 28.22 | -24.48% | $333.8 | $11.83 |
| Jun 2024 | 37.37 | -5.96% | $411.85 | $11.02 |
| Mar 2024 | 39.74 | 19.27% | $404.15 | $10.17 |
| Dec 2023 | 33.32 | 21.52% | $306.53 | $9.2 |
| Sep 2023 | 27.42 | -1.12% | $242.13 | $8.83 |
| Jun 2023 | 27.73 | 20.62% | $240.17 | $8.66 |
| Mar 2023 | 22.99 | -18.07% | $188.05 | $8.18 |
| Dec 2022 | 28.06 | 21.21% | $212.41 | $7.57 |
| Sep 2022 | 23.15 | -7.03% | $157.17 | $6.79 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of MEDP is lower than the 3 and 5-year averages.
Medpace Holdings's P/E of 28.81 is above the Healthcare sector average but below the industry average. In comparison with its Healthcare sector average of 24.29, Medpace Holdings's P/E is 19% higher.
In comparison to its peer stocks OMER and ORMP, MEDP's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| VIVS VivoSim Labs Inc. | 0.67 | $3.05M |
| ORMP Oramed Pharmaceuticals Inc | 1.46 | $158.79M |
| OMER Omeros Corp | 7.38 | $694.8M |
| MEDP Medpace Holdings Inc | 28.93 | $13.4B |
| OLMA Olema Pharmaceuticals Inc | N/A | $869.98M |
| ORIC Oric Pharmaceuticals Inc | N/A | $867.48M |
The price to earnings ratio for MEDP stock is 28.81 as of Jun 12, 2026.
As an average over the last 3 years, MEDP stock has a PE ratio of 30.42.
As an average over the last 5 years, MEDP stock has a PE ratio of 30.47.
The highest quarterly PE ratio in the last ten years has been 248.83 and it was in the Sep 2016 quarter.
MEDP's current price to earnings ratio is 27% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 12, 2026), Medpace Holdings's stock price is $467.34. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $16.22. Therefore, Medpace Holdings's PE ratio for today is 28.81. PE RATIO(28.81) = STOCK PRICE($467.34) / TTM EPS($16.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.